Skip to main content

ALLOPURINOL

NDC 53401-025 · Aphena Pharma Solutions - Tennessee, LLC

Generic nameALLOPURINOL
Dosage formTABLET
RouteORAL
Active ingredient(s)ALLOPURINOL
Strength300 mg/1
Pharmacologic classXanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
Marketing categoryANDA

Packages

53401-025-60 — 90 TABLET in 1 BOTTLE (53401-025-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-7833 — Allopurinol, 51079-205 — allopurinol, 51079-206 — allopurinol, 51655-082 — Allopurinol, 51655-523 — allopurinol, 51655-546 — allopurinol, 51655-782 — allopurinol, 51655-945 — Allopurinol, 51655-968 — Allopurinol, 53401-019 — ALLOPURINOL, 53489-156 — Allopurinol, 53489-157 — Allopurinol, 55111-729 — allopurinol, 55111-730 — allopurinol, 55154-0282 — allopurinol, 55154-2338 — Allopurinol, 55154-5454 — Allopurinol, 55154-5534 — Allopurinol, 55154-7981 — allopurinol, 59651-285 — Allopurinol, +142 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T50.4X1 — Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), T50.4X2 — Poisoning by drugs affecting uric acid metabolism, intentional self-harm, T50.4X3 — Poisoning by drugs affecting uric acid metabolism, assault, T50.4X4 — Poisoning by drugs affecting uric acid metabolism, undetermined, T50.4X5 — Adverse effect of drugs affecting uric acid metabolism, T50.4X6 — Underdosing of drugs affecting uric acid metabolism